{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:53:57Z","timestamp":1782755637786,"version":"3.54.5"},"reference-count":9,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"DOI":"10.1093\/jac\/dkw464","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T19:05:48Z","timestamp":1475607948000},"page":"dkw464","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and tolerance of dolutegravir-based combined ART in perinatally HIV-1-infected adolescents: a French multicentre retrospective study"],"prefix":"10.1093","author":[{"given":"Coralie","family":"Briand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dollfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Faye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Avettand-Fenoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Caseris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Dominique","family":"Tabone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Vaudre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Veber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Blanche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Frange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"key":"2016122017351723000_dkw464v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60208-0"},{"key":"2016122017351723000_dkw464v1.2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0256-y"},{"key":"2016122017351723000_dkw464v1.3","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/INF.0000000000000848","article-title":"Safety, pharmacokinetics and efficacy of dolutegravir in treatment-experienced HIV-1 infected adolescents: forty-eight-week results from IMPAACT P1093","volume":"34","author":"Viani","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"2016122017351723000_dkw464v1.4","unstructured":"Van den Berk G Oryszczyn J Blok W . Unexpectedly high rate of intolerance for dolutegravir in real life setting. In: Abstracts of the Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2016. Abstract P948. Foundation for Retrovirology and Human Health, Alexandria, VA, USA."},{"key":"2016122017351723000_dkw464v1.5","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/QAD.0b013e3283553776","article-title":"CCR5 antagonists: a therapeutic option in HIV-1 perinatally infected children experiencing virological failure","volume":"26","author":"Frange","year":"2012","journal-title":"AIDS"},{"key":"2016122017351723000_dkw464v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61221-0"},{"key":"2016122017351723000_dkw464v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61853-4"},{"key":"2016122017351723000_dkw464v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60084-2"},{"key":"2016122017351723000_dkw464v1.9","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1097\/QAD.0000000000001191","article-title":"The M184I\/V and K65R nucleoside resistance mutations in HIV-1 prevent the emergence of resistance mutations against dolutegravir","volume":"30","author":"Oliveira","year":"2016","journal-title":"AIDS"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/3\/837\/13760843\/dkw464.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T02:42:05Z","timestamp":1503628925000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkw464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":9,"alternative-id":["10.1093\/jac\/dkw464"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw464","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,20]]}}}